Navigating Dual Roles: Insights from Qiaoni 'Linda' Jing and Frank Kurre on the CEO and Board Member Dynamic

Our Blind Spots in the Boardroom series is focused on critical business issues that can significantly impact an organization's strategy and operations, particularly those that the board and/or C-suite are not focused on at all or enough.   In this episode, Qiaoni "Linda" Jing and Frank Kurre explore the complexities of being both a CEO and board member. Linda shares strategies for effective role execution and efficient decision-making in the boardroom, offering insights on managing these dual responsibilities.Linda serves as the President, CEO, and Board Director of Genective, a joint venture between Limagrain and KWS, focusing on sustainable biotech solutions for seeds. She played a pivotal role in transforming Genective into an operationally independent company. Previously, Linda held various executive roles at Monsanto, covering commercial, supply chain, R&D, and corporate affairs. She is Directorship Certified™ by the National Association of Corporate Directors (NACD) and recognized as one of the inaugural 50 Women to Watch for Boards in North America. Additionally, she is a member of the NYSE’s Board Advisory Council, a finalist for the EY Entrepreneur of the Year® Award in the U.S. Midwest, and part of the Young Presidents Organization and Extraordinary Women on Boards. Linda contributes to her community as a Board Director for Forest Park Forever and the U.S. Heartland China Association. Holding an MBA, an MA in Economics, and a BS in Industrial Engineering, Linda is a naturalized U.S. citizen fluent in Mandarin and English, with working proficiency in Spanish.With more than 40 years of experience in consulting, Kurre guides Protiviti’s global board, CEO and alumni programs. He is also a senior advisor to Protiviti's Global Private Equity and Public Sector (Not for Profit) practices and leads several of the firm's strategic initiatives and accounts. During his career, Kurre has advised more than 200 boards – including many Fortune 1000 companies, and Russell 1000 and Russell 2000 public companies – on board governance, finance, financial reporting, internal audit, leadership development, risk management, and strategic planning.  For further information on this and other relevant topics for the boardroom, visit our Board and C-Suite Leadership insights collection on Protiviti’s website.  For information about Frank and to contact him, visit www.protiviti.com/us-en/frank-kurre.For more information about Linda and to contact her, visit https://www.linkedin.com/in/qiaonilindajing/.